Incidence of osteonecrosis of the jaw (ONJ) in cancer patients with bone metastases treated with bisphosphonates and/or denosumab: some comments and questions

Acta Clin Belg. 2018 Apr;73(2):163-164. doi: 10.1080/17843286.2017.1389473. Epub 2017 Nov 7.

Authors

Vittorio Fusco¹, Maura Rossi¹, Iolanda De Martino¹, Manuela Alessio¹, Antonella Fasciolo¹, Gianmauro Numico¹

Affiliation

¹ a Azienda Ospedaliera di Alessandria , Alessandria , Italy.

PMID: 29111914
DOI: 10.1080/17843286.2017.1389473

No abstract available

Publication types

Letter
Comment

MeSH terms

Bone Density Conservation Agents
Bone Neoplasms
Denosumab*
Diphosphonates*
Humans
Incidence
Osteonecrosis

Substances

Bone Density Conservation Agents
Diphosphonates
Denosumab